Skip to content

The effect of local xylocaine injection on post cesarean pain

Comparision between the different methods of local xylocaine injection on post cesarean pain

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201012275485N1
Enrollment
200
Registered
2011-05-23
Start date
2009-11-19
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pain after cesarean. Delivery by elective caesarean section

Interventions

Intervention 1: Group1: 20 ml of 1% xylocaine containing 10mcg/ml epinephrine will be injected at outer 1/4 portion of the line between umbilicus and upper anterior iliac crest , in lateral part of r
Treatment - Drugs
Group1: 20 ml of 1% xylocaine containing 10mcg/ml epinephrine will be injected at outer 1/4 portion of the line between umbilicus and upper anterior iliac crest , in lateral part of rectus abdominus
Group2: 20 ml of 1% xylocaine containing 10mcg/ml epinephrine will be injected in subcutaneous tissue in the manner of infiltrating the whole wound, before closure of the abdominal wall.
Group3: 10 ml of 1% xylocaine containing 10mcg/ml epinephrine will be injected at outer 1/4 portion of the line between umbilicus and upper anterior iliac crest , in lateral part of rectus abdominus
Group4: 20 ml normal saline will be injected before closure of subcutaneous tissue.

Sponsors

Vice chancellor for research,Tabriz University of Medical Sciences , Women Fertility Health Research
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
25 Years to 35 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria are the following: term pregnancy; one previous cesarean section; low transverse scar on the abdomen ; elective cesarean section with transverse incision on the skin and lower uterine segment: age between 25 to 35 ; spinal anesthesia; tendency of the patient to participate in the study. Exclusion criteria are the following: Emergent cesareans; underlying diseases like liver and kidney dysfunction and impaired hemostasis and … ; history of previous surgery at the surgical site or on the suprapubic site except cesarean section; low midline scar on the abdomen ; Positive history of smoking or drug abuse; drug sensitivity to topical analgesics .

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Post cesarean pain. Timepoint: 0.5 ,1 ,2 ,3 ,6 ,12 ,24 hour. Method of measurement: visual analogue scale.

Secondary

MeasureTime frame
Rate of cesarean wound healing and repair. Timepoint: 2 ,3 ,7 day after cesarean. Method of measurement: physical examination.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr.Nazli Navali

Tabriz University of Medical Sciences, Faculty of medicine, Obstetrics and gynecology group

navalin@tbzmed.ac.ir+98 41 1334 5416

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026